{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:26:51Z","timestamp":1767184011197,"version":"build-2238731810"},"reference-count":0,"publisher":"American Academy of Pediatrics (AAP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1992,10,1]]},"abstract":"<jats:p>The benzodiazepines have replaced widespread use of barbiturates and other sedatives. They are effective, safe medicines used to treat a variety of disorders associated with excessive CNS excitability. Although many physicians avoid prescribing benzodiazepines to adolescents, there is little evidence to support this practice. Unless an adolescent has a history of substance abuse\/dependence and suicidal ideation, the benzodiazepines are safe. Benzodiazepine toxicity rarely occurs unless another CNS depressant, especially alcohol, is used concurrently.<\/jats:p>","DOI":"10.1542\/pir.13.10.381","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T02:43:55Z","timestamp":1639190635000},"page":"381-386","source":"Crossref","is-referenced-by-count":6,"title":["Depressant Substances in Adolescent Medicine"],"prefix":"10.1542","volume":"13","author":[{"given":"Robert L.","family":"DuPont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith E.","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1992,10,1]]},"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/13\/10\/381\/986006\/381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/13\/10\/381\/986006\/381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T09:27:16Z","timestamp":1640078836000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/13\/10\/381\/35840\/Depressant-Substances-in-Adolescent-Medicine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,10,1]]},"references-count":0,"aliases":["10.1542\/pir.13-10-381"],"journal-issue":{"issue":"10","published-online":{"date-parts":[[1992,10,1]]},"published-print":{"date-parts":[[1992,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.13.10.381","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"value":"0191-9601","type":"print"},{"value":"1526-3347","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,10,1]]}}}